Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Yellow fever (YF), caused by YF virus, is a zoonotic disease characterized by fever and constitutional symptoms, with the potential to progress to severe and fatal viral hemorrhagic fever with shock and multi-organ system failure.
Features include very common findings: Fever, Nausea, Increased circulating IgM level, and Viremia and others; and common findings: Reduced kidney function (renal insufficiency), Bradycardia, Abnormal bleeding tendency (abnormal bleeding), and Acute kidney injury and others. 47 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 7 | Nausea, Vomiting, Abdominal pain |
Biomarker and diagnostic research for yellow fever has been reported in the published literature.
Phenotype severity distribution: 5 very common features, 18 common features.
Estimated prevalence: Unknown (Unknown prevalence).
14 clinical trials registered, 5 recruiting. Interventions under study include biologic therapy, other interventions, and procedural interventions. Pipeline includes 2 PHASE4, 2 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06694766](https://clinicaltrials.gov/study/NCT06694766) |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Lab test results |
6 |
Elevated circulating alanine aminotransferase concentration, Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated creatinine (kidney function marker) (elevated circulating creatinine concentration) |
Blood and immune system | 6 | Abnormal bleeding tendency (abnormal bleeding), Excessive bleeding after a venipuncture, Low platelet count (thrombocytopenia) |
Kidneys and urinary system | 3 | Reduced kidney function (renal insufficiency), Acute kidney injury, Elevated creatinine (kidney function marker) (elevated circulating creatinine concentration) |
Heart and blood vessels | 3 | Bradycardia, Supraventricular arrhythmia, Reduced left ventricular ejection fraction |
Brain and nerves | 3 | Headache, Seizure, Status epilepticus |
Metabolism | 2 | Fever, Metabolic acidosis |
Bones and joints | 1 | Arthralgia |
Muscles | 1 | Myalgia |
Skin | 1 | Skin rash |
VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever) |
NA |
Institut Pasteur |
RECRUITING |
[NCT05859490](https://clinicaltrials.gov/study/NCT05859490) | Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination | PHASE1 | Oregon Health and Science University | RECRUITING |
[NCT07358910](https://clinicaltrials.gov/study/NCT07358910) | Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective | — | Institut Pasteur du Cambodge | RECRUITING |
[NCT07103148](https://clinicaltrials.gov/study/NCT07103148) | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | PHASE3 | Sanofi | RECRUITING |
[NCT07636551](https://clinicaltrials.gov/study/NCT07636551) | Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants | NA | Institute of Tropical Medicine, Belgium | RECRUITING |
355 publications have been identified in PubMed for yellow fever. Kisho has analyzed 182 by research type. Research spans Review / Meta-Analysis (30%), Epidemiology / Natural History (27%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 54 | 30% |
Disease patterns and progression | 50 | 27% |
Laboratory research | 33 | 18% |
Clinical study results | 14 | 8% |
Other research | 11 | 6% |
Testing and diagnosis research | 9 | 5% |
New treatment approaches | 9 | 5% |
Patient case studies | 2 | 1% |
Saucha CVV (2026). [PMID: 41830133](https://pubmed.ncbi.nlm.nih.gov/41830133/). *Trans R Soc Trop Med Hyg*. [Epidemiology / Natural History]
Farsiu N (2026). [PMID: 42125402](https://pubmed.ncbi.nlm.nih.gov/42125402/). *Front Microbiol*. [Review / Meta-Analysis]
Fraser K (2026). [PMID: 42260694](https://pubmed.ncbi.nlm.nih.gov/42260694/). *BMC Glob Public Health*. [Epidemiology / Natural History]
Binderup A (2026). [PMID: 41765050](https://pubmed.ncbi.nlm.nih.gov/41765050/). *Antiviral Res*. [Basic Science / Preclinical]
Akther F (2026). [PMID: 41198509](https://pubmed.ncbi.nlm.nih.gov/41198509/). *Trends Immunol*. [Review / Meta-Analysis]
Aquino VH (2026). [PMID: 42250476](https://pubmed.ncbi.nlm.nih.gov/42250476/). *Vaccine*. [Review / Meta-Analysis]
Bailey AL (2026). [PMID: 41802272](https://pubmed.ncbi.nlm.nih.gov/41802272/). *The Journal of infectious diseases*. [Gene Therapy / Novel Therapeutics]
Duarte-Neto AN (2026). [PMID: 41714603](https://pubmed.ncbi.nlm.nih.gov/41714603/). *Emerg Infect Dis*. [Epidemiology / Natural History]
Telles-de-Deus J (2026). [PMID: 41813975](https://pubmed.ncbi.nlm.nih.gov/41813975/). *Nat Microbiol*. [Epidemiology / Natural History]
Rodríguez-Morales AJ (2026). [PMID: 41786198](https://pubmed.ncbi.nlm.nih.gov/41786198/). *Travel Med Infect Dis*. [Other]
AI-curated news mentioning yellow fever
Updated Apr 24, 2026
A recent study highlights the impact of a yellow fever virus outbreak on the survival and dispersal patterns of wild golden lion tamarins. This research underscores the ecological consequences of viral infections in wildlife populations.
The CDC provides an update on the yellow fever outbreak in Brazil, emphasizing vaccination recommendations to mitigate the spread. This information is crucial for public health awareness and response efforts.
The CDC warns travelers to Brazil about a deadly outbreak of yellow fever, urging vaccination before travel. This advisory highlights the ongoing public health risk associated with the disease in the region.
CDC announces a media teleconference to address the ongoing yellow fever outbreak in Brazil, as detailed in the March 16 Morbidity and Mortality Weekly Report. The advisory includes vaccination recommendations to combat the spread of this deadly disease.